Formulation to improve survival of transplanted cells
US7875451B2 · kind B2 · utility
21Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2006 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Mar 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The survival of cells during transplantation is enhanced. Cells to be transplanted are administered in a formulation that provides two ore more survival enhancing factors. Optionally, prior to administration, the cells are cultured in the presence of factors that enhance survival, and may be heat shocked prior to transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.